Sintilimab in Combination With Bevacizumab and Temozolomide in Recurrent Glioblastoma (GBM) Patients
Clinical trial NCT05638451 · UNKNOWN
Trial details
- NCT number
- NCT05638451
- Sponsor
- Zhujiang Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-01
- Primary completion
- 2024-12-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.